Clinical trial Recruiting at 7 sites Observational Ages 21 and up Women only

Registry to evaluate pelvic mesh products for urinary incontinence and prolapse

Official title: A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) Registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse

Run by Ethicon, Inc. · NCT04829175 · Data updated 2026-11-12

This study is testing how well certain surgical mesh products work for women having surgery for urinary incontinence and pelvic organ prolapse, while also looking at their safety and any complications after the surgery.

More Stress Urinary Incontinence trials

Quick facts

Study typeObservational
Ages21 Years and up
SexWomen only
Enrollment1000 (estimated)
SponsorEthicon, Inc.
Industry-sponsored
Locations10 sites (New Haven, Connecticut and 9 other locations)
StatusRecruiting
StartedApril 11, 2022
Main results expectedMarch 31, 2033
Study endsMarch 31, 2038
Registry record updatedJuly 6, 2026
Trial IDNCT04829175 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 21 and older with confirmed stress urinary incontinence or pelvic organ prolapse who are planning to undergo surgical correction.

Probably not a fit

Patients who do not have stress urinary incontinence or pelvic organ prolapse, or those who are not planning to undergo surgery, may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to assess the performance of the TVT family of products and synthetic mesh used in surgeries for stress urinary incontinence (SUI) and pelvic organ prolapse (POP). It includes women who are undergoing surgical correction for these conditions, with a focus on the effectiveness and safety of the Gynemesh PS Mesh and Artisyn Mesh. Participants will be followed up post-surgery to gather data on outcomes and any complications that may arise. The study is designed to provide insights into the long-term performance of these surgical interventions.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding of pelvic mesh products, leading to improved surgical outcomes for women with SUI and POP.

How similar studies have gone: Other studies evaluating pelvic mesh products have shown varying degrees of success, but this registry focuses specifically on post-market performance, making it a valuable addition to existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients who satisfy all of the following criteria will be considered eligible for enrollment in this registry:

SUI

1. Stress urinary incontinence symptoms
2. Urodynamic stress incontinence confirmed with urodynamic testing
3. Female patient ≥ 21 years of age
4. Desired surgical correction of SUI using synthetic pubo-urethral vaginal sling
5. Planned surgery for primary SUI
6. Patient able and willing to participate in follow-up
7. Patient or authorized representative has signed the approved Informed consent POP

1\. Uterine or vaginal vault prolapse symptoms 2. Urodynamic testing (optional) 3. Female patient ≥ 21 years of age 4. Desired surgical correction of POP using synthetic mesh 5. Planned surgery for uterine or vaginal vault prolapse with or without concomitant SUI surgery 6. Patient able and willing to participate in follow-up 7. Patient or authorized representative has signed the approved Informed consent

Exclusion Criteria

Patients meeting any of the following criteria will be considered not eligible for enrollment in this registry:

1. Physical or psychological condition which would impair registry participation or are unwilling or unable to participate in all required registry visits and are unable to complete the questionnaires
2. Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of registry products
3. History of previous synthetic, biologic or fascial sub-urethral sling (SUI) or pelvic mesh (POP)
4. Pregnancy or plans for future pregnancy
5. History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice
6. Current genitourinary fistula or urethral diverticulum
7. Reversible cause of incontinence (i.e. drug effect) for SUI only
8. Severe vaginal atrophy
9. History of pelvic irradiation therapy
10. Contraindication to surgery

Where it's running

  • Yale University
    New Haven, Connecticut, United States
    Recruiting
  • Duke University
    Durham, North Carolina, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Upmc
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Krankenhaus der barmherzigen Schwestern
    Linz, Austria
    Recruiting
  • Bio-Medical University Rome
    Rome, Italy
    Recruiting
Show 4 more locations
  • Karolinska Institute
    Stockholm, Sweden
    Recruiting
  • Herlev Hospital
    Hillerød, Denmark
    Not yet recruiting
  • Hopital Jeanne de Flandres
    Lille, France
    Not yet recruiting
  • Universitatsklinikum Tubingen
    Tübingen, Germany
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.